An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method (JULIA)

Bayer

Status: Completed

Conditions: Quality of Life

Treatments: Drug: Levonorgestrel (Jaydess, BAY86-5028)

Study type: Observational

Funder types: Industry

Identifiers

NCT02574715

18096

Details and patient eligibility

About

This is a cross-sectional, multicenter observational study to assess quality of life in young Spanish women (aged 18 to 29) who use Jaydess® as their contraceptive method. The study will be conducted in standard clinical practice conditions at the private gynecology clinics and during a single study visit.

Approximately 1,200 women who have been using the intrauterine delivery system (IUS) Jaydess® as their contraceptive method of choice for 6 (±1) months will be included in the study.

Enrollment: 1,039 patients

Sex: Female

Ages: 18 to 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women aged 18 to 29 years.
• Women who have been using Jaydess as their contraceptive method for 6 (±1) months.
• Women who have no comprehension, reading or writing challenges.
• Women who have given informed consent in writing.

Exclusion criteria

• Contraindication to the use of Jaydess.
• Prescription of Jaydess® for non-contraceptive medical reasons.
• Women who are considered to be unsuitable to take part in the study by the investigator (e.g., poor understanding of the study characteristics, uncooperative, etc.).
• Women who are currently taking part in any clinical trial.

Trial design

1,039 participants in 1 patient group

Levonorgestrel (Jaydess, BAY86-5028)

Description:

women aged 18 to 29 years following 6 (±1) months of Jaydess® use as their contraceptive method.

Treatment:

Drug: Levonorgestrel (Jaydess, BAY86-5028)